Alembic Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on July 31, 2015, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on June 30, 2015 (Q1). Further, the Exchange is hereby informed that the trading window shall remain closed from July 28, 2015 to August 02, 2015 for the above purpose.
The above information is a part of company’s filings submitted to BSE.